Industry Insights
Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold
Industry InsightWith constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.
Read More
Thermo Fisher Scientific Joins the Pistoia Alliance
Industry InsightRecently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.
Read More
Celebrations All Round for Analysis Veterans
Industry InsightAs a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.
Read More
Infection Identification: Metagenomic Next-generation Sequencing vs PCR
Industry InsightWe recently spoke with Meredith Carpenter, Director of Assay Research and Development for Arc Bio, to learn more about the capabilities of metagenomic next-generation sequencing in identifying infections.
Read More
How a Female Executive Became a Leader in the Business of Science
Industry InsightTrisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.
Read More
Technology Networks Explores the CRISPR Revolution: An Interview With Dr Amy Butler
Industry InsightIn this week's instalment of "Technology Networks Explores the CRISPR Revolution", we're focusing on the technical elements of CRISPR technology. Helping us to answer key questions in this space is Dr Amy Butler, President of the Biosciences Division at Thermo Fisher Scientific.
Read More
Detecting Rare Diseases With Whole Exome Sequencing
Industry InsightGenomic approaches, such as whole exome sequencing, can provide key information to help experts detect rare diseases, but their use still presents challenges. We recently spoke with Gioia Althoff, Vice President, Genomics, at SOPHiA GENETICS, to learn more about the role that whole exome sequencing can play in the fight against rare diseases and how their new solution can help.
Read More
Exploring Droplet Digital PCR Technology
Industry InsightRecently, we interviewed George Karlin-Neumann, Clinical Director, Digital Biology Group at Bio-Rad Laboratories to learn more about ddPCR and its applications.
Read More
The Longitude Challenge - Developing a Diagnostic Test To Fight Antimicrobial Resistance
Industry InsightWe recently spoke with Daniel Berman, Global Health Lead at Nesta Challenges, to learn about the Longitude Prize, a £10 million prize fund with an £8 million pay-out, which will be awarded to a team that invents an affordable, accurate, fast and easy-to-use test for bacterial infections.
Read More
Collaboration Is the X Factor in Making Precision Medicine a Success
Industry InsightCompanion diagnostics (CDx), i.e. in vitro medical devices, and next-generation sequencing (NGS), are both essential to the practice of precision medicine. As new regulations are introduced, pharma companies and manufacturers alike need to ensure their CDx processes are compliant or we could see a deceleration in the flow of new precision therapies in the near future.
Read More
